| Bioactivity | Ertapenem (MK-0826) is a broad spectrum and long acting β-lactam antibiotic. Ertapenem has a broad-spectrum anti-anaerobic activity against a variety of anaerobes with a mode MIC of 0.12 μg/mL. Ertapenem can be used for the research of severe infections caused by bacteria in the skin, lungs, stomach, pelvis, and urinary tract[1][2]. |
| Invitro | Ertapenem (0-100 μg/mL approximately, 48 h) is active against 99.1% of all anaerobes with a mode MIC of 0.12 μg/mL and MIC90 of 1 μg/mL, and MIC’s ≥8 μg/mL for B.fragilis and B.vulgatus species, respectively[1]. Cell Viability Assay[1] Cell Line: |
| Name | Ertapenem |
| CAS | 153832-46-3 |
| Formula | C22H25N3O7S |
| Molar Mass | 475.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Ertapenem
CAS: 153832-46-3 F: C22H25N3O7S W: 475.51
Ertapenem (MK-0826) is a broad spectrum and long acting β-lactam antibiotic. Ertapenem has a broad-spectrum anti-anaero
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.